CBR Systems Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CBR Systems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3383
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CBR Systems Inc (CBR), a subsidiary of AMAG Pharmaceuticals Inc, is a stem cell company that offers new born stem cells. The company provides collection, processing, and long-term cryopreservation services for newborn umbilical cord blood stem cells and cord tissue units. It offers cord blood stem cells for the treatment of cerebral palsy, autism, acquired hearing loss, and pediatric strokes, diabetes, skeletal disease and injury, vascular damage, gastrointestinal disease, and others. CBR serves directly to pregnant women and their families through social media and electronic marketing. The company’s laboratories are located in Tucson and Arizona, the US. CBR Systems is headquartered in San Bruno, California, the US.

CBR Systems Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CBR Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CBR Systems Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
GI Partners Acquires CBR Systems from AMAG Pharma for USD530 Million 10
GTCR Invests In Cord Blood Registry 12
Partnerships 13
Cord Blood Registry Enters into Research Agreement with Cellular Dynamics 13
Acquisition 14
AMAG Pharma Acquires Cord Blood Registry for USD700 Million 14
CBR Systems Inc – Key Competitors 16
CBR Systems Inc – Key Employees 17
CBR Systems Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
CBR Systems Inc, Pharmaceuticals & Healthcare, Key Facts 2
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CBR Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CBR Systems Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GI Partners Acquires CBR Systems from AMAG Pharma for USD530 Million 10
GTCR Invests In Cord Blood Registry 12
Cord Blood Registry Enters into Research Agreement with Cellular Dynamics 13
AMAG Pharma Acquires Cord Blood Registry for USD700 Million 14
CBR Systems Inc, Key Competitors 16
CBR Systems Inc, Key Employees 17

List of Figures
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CBR Systems Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asatsu-DK Inc.:企業の戦略的SWOT分析
    Asatsu-DK Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Golden Star Resources Ltd:企業の戦略・SWOT・財務情報
    Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Esprinet SpA (PRT):企業の財務・戦略的SWOT分析
    Esprinet SpA (PRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Traverse Energy Ltd (TVL):企業の財務・戦略的SWOT分析
    Summary Traverse Energy Ltd (Traverse Energy), formerly Firstland Energy Ltd is an oil and gas company that explores, produces, and develops petroleum and natural gas assets. The company's products include crude oil, natural gas, petroleum products, and associated liquids, among others. It explores …
  • Hwa Tai Industries Berhad:企業の戦略・SWOT・財務分析
    Hwa Tai Industries Berhad - Strategy, SWOT and Corporate Finance Report Summary Hwa Tai Industries Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Evolution Petroleum Corp (EPM):企業の財務・戦略的SWOT分析
    Summary Evolution Petroleum Corp (EPC), a subsidiary of Esrey Resources Ltd, is an oil and gas company that acquires and explores crude oil and natural gas properties. The company explores for oil, liquefied gas, natural gas, and gas reserves in Delhi field CO2-EOR project. It offers GARP or gas ass …
  • Inivata Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Inivata Ltd (Inivata) is a cancer genomics company. The company offers products such as invisionfirst- lungin and visionseq. Its InVisionFirst offers advanced sequencing technology to detect single nucleotide variants copy number variants, insertions and deletions and structural variants in …
  • Probi AB (PROB):企業の財務・戦略的SWOT分析
    Probi AB (PROB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • ResMed Inc. (RMD)-医療機器分野:企業M&A・提携分析
    Summary ResMed Inc. (ResMed) develops, manufactures and distributes medical equipment for the diagnosis, treatment and management respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include air flow generato …
  • Coutts & Co:企業の戦略・SWOT・財務情報
    Coutts & Co - Strategy, SWOT and Corporate Finance Report Summary Coutts & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Equity Residential:企業の戦略・SWOT・財務情報
    Equity Residential - Strategy, SWOT and Corporate Finance Report Summary Equity Residential - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ibersol S.G.P.S., S.A.:企業の戦略・SWOT・財務分析
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MedEquities Realty Trust, Inc. (MRT):企業の財務・戦略的SWOT分析
    MedEquities Realty Trust, Inc. (MRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Hankook Tire & Technology Co Ltd (161390):企業の財務・戦略的SWOT分析
    Hankook Tire & Technology Co Ltd (161390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Ascletis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ascletis Inc (Ascletis) is a healthcare company that provides therapeutics for cancer and infectious diseases. The company offers discovery, demonstration of global partnering, clinical proof-of-concept, and research and development services of novel therapeutics for life-threatening disease …
  • Audi AG (NSU):企業の財務・戦略的SWOT分析
    Audi AG (NSU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Laborie Medical Technologies Inc:企業の製品パイプライン分析2018
    Summary Laborie Medical Technologies Inc (Laborie), a subsidiary of Patricia Industries AB, develops and manufactures medical diagnostics and devices. The company offers uroflowmetry, urodynamics, pelvic floor rehabilitation and anorectal manometry products and related consumables. It also provides …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆